Blood Screening Market is anticipated to expand at a compound annual growth rate (CAGR) 6.9% from 2021 to 2031 | Grifols (Spain), F. Hoffmann-La Roche Ltd. (Switzerland), Abbott Laboratories, Inc. (US)

The blood screening market size was USD 2.8 billion in 2021 and it is anticipated to reach USD 5.5 billion in 2031, growing at a CAGR of 6.9% from 2022-2031.

Global Blood Screening Market report from Global Insight Services is the single authoritative source of intelligence on Blood Screening Market. The report will provide you with analysis of impact of latest market disruptions such as Russia-Ukraine war and Covid-19 on the market. Report provides qualitative analysis of the market using various frameworks such as Porters' and PESTLE analysis. Report includes in-depth segmentation and market size data by categories, product types, applications, and geographies. Report also includes comprehensive analysis of key issues, trends and drivers, restraints and challenges, competitive landscape, as well as recent events such as M&A activities in the market.

Read more about Blood Screening Market here: https://www.globalinsightservices.com/reports/blood-screening-market/

Blood screening is a medical process in which blood is examined for a specific disease or condition. It aids in monitoring disease and preventing health issue and a variety of other conditions such as infection and cancer. Human Immunodeficiency Virus (HIV), blood type, and pregnancy screenings are the most common types of blood screening.

Market Trends and Drivers:

The key factor boosting the market growth is an increasing number of blood donations across the globe. There is an increase in the need for donated blood owing to advancements in healthcare systems and the availability of and the need for sophisticated surgical procedures, like cardiovascular & transplant surgery, trauma care, and therapy for cancer and blood diseases. On an average around 235 million major surgeries are being performed across the globe every year, of which 63 million are traumatic surgeries, cancer-related are over 31 million, and 10 million are related to pregnancy complications. Blood transfusion is generally prescribed in complicated childbirth to prepare for childhood congenital maternal blood disorders, acute anemia, and trauma.

To Remain 'Ahead' Of Your Competitors, Request for A Sample - https://www.globalinsightservices.com/request-sample/GIS10245

Market Segments:

By Product & Services
Reagents & Kits
Instruments
Software & Services

By Technology
Nucleic Acid Test
ELISA
Rapid Tests
Western-Blot Assays
Next-Generation Sequencing

By End User
Blood Banks
Hospitals

Key Players:

Grifols (Spain)
F. Hoffmann-La Roche Ltd. (Switzerland)
Abbott Laboratories, Inc. (US)
bioMérieux (France)
Bio-Rad Laboratories, Inc. (US)
Becton, Dickinson and Company (US)
Beckman Coulter, Inc. (Danaher) (US)

Request For Customization - https://www.globalinsightservices.com/request-customization/GIS10245/

With Global Insight Services, you receive:

- 10-year forecast to help you make strategic decisions
- In-depth segmentation which can be customized as per your requirements
- Free consultation with lead analyst of the report
- Excel data pack included with all report purchases
- Robust and transparent research methodology

Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700

About Global Insight Services:
Global Insight Services (GIS) is a leading multi-industry market research firm
headquartered in Delaware, US. We are committed to providing our clients
with highest quality data, analysis, and tools to meet all their market research
needs. With GIS, you can be assured of the quality of the deliverables, robust
& transparent research methodology, and superior service.

This release was published on openPR.